
Last updated: 2026-09-06 11:20:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Prestige Consumer Healthcare Inc. (PBH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $52,25, with a market capitalization of $2,48B and a P/E ratio of 14,39. Over the past 52 weeks, its price has ranged from $42,62 to $71,07. This page covers its latest market performance, valuation, price trends and company information.
$2,48B | |
$51,80 | |
$90,04 | |
$3,92 | |
$52,56 | |
260,28K | |
580,27K | |
14,39 | |
$71,07 | |
$42,62 | |
-- | |
-- |
Prestige Consumer Healthcare Inc. (PBH) last closed at $52,56 as of 2026-09-04 23:44:00, unchanged from the previous close of $52,56.
During the latest regular trading session, PBH traded between $3,92 and $90,04, with a volume of 260,28K shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Prestige Consumer Healthcare Inc. (PBH) moved from $51,21 to $52,25, representing a gain of 2,03% ($1,04).
The stock traded between $51,08 and $53,95 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 414,45 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 33,8%
PBH is currently trading at $52,25, placing it 33,8% of the way from its 52-week low of $42,62 to its 52-week high of $71,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 890 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Prestige Consumer Healthcare Inc. (PBH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.